64
Registered trials
26
Recruiting
28
Completed trials
49
Sponsors
24
Countries
Phase III:
24
Phase II/III:
2
Phase II:
15
Phase I/II:
1
Phase III/IV:
1
Phase IV:
20
Other:
1
Oversight events:
3 serious breaches
1 temporary halt
1 urgent safety measure
2 corrective measures
across 6 trials
View oversight register →
Indications tested
Chronic kidney disease
7
Type 2 diabetes mellitus
3
IgA nephropathy
3
Hypertension
3
Acute myocardial infarction
2
Cardiac failure
2
Heritable pulmonary arterial hypertension
1
Obesity
1
Glomerulonephritis membranous
1
Laboratory test abnormal
1
Pulmonary arterial hypertension
1
Cardiac amyloidosis
1
Sponsors using this IMP
AstraZeneca AB
9
Novo Nordisk A/S
3
Odense University Hospital
3
Assistance Publique Hopitaux De Paris
2
Centre Hospitalier Universitaire De Nantes
2
Eli Lilly & Co.
2
Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA
2
Oslo University Hospital HF
2
Region Midtjylland
2
Universitaetsmedizin Goettingen
2
4 Wojskowy Szpital Kliniczny Z Polikliniką Samodzielny Publiczny Zaklad Opieki Zdrowotnej We Wroclawiu
1
Aarhus University Hospital
1
All trials — page 3
64 total-
DapaBalci-Leap Ended
-
MERCURI-2 Ended
Showing 49–64 of 64 trials